| Literature DB >> 23826214 |
Nicola Grossheinrich1, Maren Reinl, Oliver Pogarell, Susanne Karch, Christoph Mulert, Monika Brueckl, Kristina Hennig-Fast, Anne Rau, Maria Epple, Ariane Hornig, Frank Padberg.
Abstract
During the last decade, repetitive transcranial magnetic stimulation (rTMS) of the prefrontal cortex has become established as a treatment for various mental diseases. The rational of prefrontal stimulation has been adapted from the mode of action known from rTMS using motor-evoked potentials though little is known about the precise effect of rTMS at prefrontal sites. The objective of the current study is to investigate the inhibitory effect of prefrontal 1 Hz rTMS by stimulating the generators of event-related potentials (ERP) which are located in the prefrontal cortex. Thus, 1 Hz rTMS was applied offline over the left dorsolateral prefrontal cortex (DLPFC) and the medial prefrontal cortex (MPFC) in 18 healthy subjects who subsequently underwent a GoNogo task. Both active conditions were compared to sham rTMS within a randomized and counterbalanced cross-over design in one day. ERPs were recorded during task performance and the N2 and the P3 were analysed. After 1 Hz rTMS of the left DLPFC (but not of the MPFC), an inhibitory effect on the N2 amplitude was observed, which was related to inhibitory control. In contrast, after 1 Hz rTMS of the MPFC (but not at the left DLPFC) a trend towards an increased P3 amplitude was found. There was no significant modulation of latencies and behavioural data. The results argue in favour of an inhibitory effect of 1 Hz rTMS on N2 amplitudes in a GoNogo task. Our findings suggest that rTMS may mildly modulate prefrontally generated ERP immediately after stimulation, even where behavioural effects are not measurable. Thus, combined rTMS-ERP approaches need to be further established in order to serve as paradigms in experimental neuroscience and clinical research.Entities:
Mesh:
Year: 2013 PMID: 23826214 PMCID: PMC3694966 DOI: 10.1371/journal.pone.0067136
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Experimental crossover design counterbalanced for stimulation sites.
ANOVA of the N2 amplitude over the left DLPFC.
| within factor | time frame t1 | time frame t2 | ||
| N = 18, df = 1 | F | p | F | p |
| electrodes (Fz, Cz) | 14.43 | <.01 | 13.14 | <.01 |
| trial type (Go, Nogo) | 15.64 | <.01 | 12.75 | <.01 |
| stimulation site (left DLPFC, sham control) | 0.12 | .74 | 0.18 | .67 |
| stimulation site × trial type | 0.04 | .84 | 1.88 | .19 |
| stimulation site × electrodes | 8.19 | .01 | 0.001 | .98 |
| trial type × electrodes | 13.48 | <.01 | 12.83 | <.01 |
| trial type × electrodes × stimulation site | 0.001 | .98 | 0.002 | .97 |
Figure 2N2 difference after stimulation overthe left DLPFC (solid lines) compared to sham control (grey lines).
Illustrated are grand averages for Nogo (A, C) and Go trials (B, D) immediately after stimulation (t1; A, B) and delayed (t2; C, D).
Figure 3P3 difference after stimulation overthe mPFC (solid lines) and sham control (grey lines).
Illustrated are grand averages for Nogo (A, C) and Go trials (B, D) immediately after stimulation (t1; A, B) and delayed (t2; C, D; N = 17).
ANOVA of the P3 amplitude over the MPFC.
| within factor | time frame t1 | time frame t2 | ||
| N = 17, df = 1 | F | p | F | p |
| electrodes (Fz, Cz) | 30.19 | <.01 | 29.97 | <.01 |
| trial type (Go, Nogo) | 66.09 | <.01 | 70.19 | <.01 |
| stimulation site (left DLPFC, sham control) | 0.60 | .45 | 0.00 | .96 |
| stimulation site × trial type | 0.00 | .99 | 1.21 | .28 |
| stimulation site × electrodes | 4.76 | .04 | 0.28 | .60 |
| trial type × electrodes | 5.70 | .03 | 7.14 | .02 |
| trial type × electrodes × stimulation site | 1.45 | .25 | 0.40 | .54 |
Figure 4Negative relationship between the Disinhibition subscale of the Sensation Seeking Scale and the N2 amplitude.